Therini Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2016-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.therinibio.com
A Study to Assess THN391 in Subjects with Alzheimer's Disease
Phase 1
Not yet recruiting
- Conditions
- Alzheimer Disease, Early Onset
- Interventions
- Drug: Placebo
- First Posted Date
- 2025-02-07
- Last Posted Date
- 2025-02-07
- Lead Sponsor
- Therini Bio, Inc.
- Target Recruit Count
- 15
- Registration Number
- NCT06814730
- Locations
- 🇳🇱
Amsterdam UMC, Amsterdam, New Hampshire, Netherlands
🇬🇧Scottish Brain Sciences, Edinburgh, United Kingdom
© Copyright 2025. All Rights Reserved by MedPath